1. Home
  2. NEOG vs MLTX Comparison

NEOG vs MLTX Comparison

Compare NEOG & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$9.75

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$19.75

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
MLTX
Founded
1981
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NEOG
MLTX
Price
$9.75
$19.75
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$10.67
$27.50
AVG Volume (30 Days)
1.9M
1.5M
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$894,661,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$479.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.56
$5.95
52 Week High
$11.43
$62.75

Technical Indicators

Market Signals
Indicator
NEOG
MLTX
Relative Strength Index (RSI) 58.44 53.56
Support Level $8.82 $15.54
Resistance Level $10.30 $21.00
Average True Range (ATR) 0.41 0.88
MACD 0.05 -0.01
Stochastic Oscillator 92.98 45.74

Price Performance

Historical Comparison
NEOG
MLTX

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: